nach oben

Erschienen in:

01.10.2011 | Original Article

Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis

verfasst von: Yuan Sun, Yoshihide Fujigaki, Masanori Sakakima, Tomoyuki Fujikura, Akashi Togawa, Yanjie Huang, Akira Hishida

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Rats that recovered from mild proximal tubule (PT) injury without renal dysfunction by subtoxic insult, developed partial resistance to subsequent nephrotoxic insult. This partial resistance was associated with reduced renal dysfunction and accelerated PT cell proliferation compared with vehicle treatment as the first insult. Here we assessed the role and potential mechanisms of accelerated PT proliferation in this acquired resistance model.

Methods

Rats at 14 days after recovering from prior mild renal damage induced by 0.2 mg/kg uranyl acetate (UA) (subtoxic dose) were rechallenged with 4 mg/kg UA (nephrotoxic dose) to establish the acquired resistance model. Cell cycle was inhibited by colchicine to examine the contribution of accelerated PT cell proliferation evaluated by in vivo bromodeoxyuridine (BrdU) labeling on acquired resistance to subsequent nephrotoxic insult. Hepatocyte growth factor (HGF)/c-Met axis and other related factors of cell cycle were analyzed.

Results

The acquired resistance to rechallenge injury with nephrotoxic dose of UA in rats recovered from mild renal injury was associated with an earlier increase in BrdU-positive PT cells, accelerated upregulation of HGF mRNA, c-Met mRNA/protein, cyclin D1, phospho-Rb and an earlier phenotypic change of PT cells. Colchicine inhibited PT cell proliferation, reduced the upregulated cyclin D1 and phospho-Rb in the kidney, completely abolishing acquired resistance.

Conclusions

Cell cycle progression with upregulated renal HGF/c-Met axis may contribute to the accelerated recovery from acute renal failure in rats that recovered from prior mild renal damage, followed by nephrotoxic insult, resulting in partial acquired resistance.

Honda N, Hishida A, Ikuma K, Yonemura K. Acquired resistance to acute renal failure. Kidney Int. 1987;31:1233–8.CrossRefPubMed

Furuya R, Kumagai H, Hishida A. Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells. J Lab Clin Med. 1997;129:347–55.CrossRefPubMed

Zager RA, Burkhart KM, Johnson AC, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and “acquired cytoresistance”. Kidney Int. 1999;56:1788–97.CrossRefPubMed

Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000;58:193–205.CrossRefPubMed

Kawaida K, Matsumoto K, Shimazu H, Nakamura K. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–61.CrossRefPubMedPubMedCentral

Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–54.CrossRefPubMed

Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–57.CrossRefPubMed

Sharples EJ. Acute kidney injury: stimulation of repair. Curr Opin Crit Care. 2007;13:652–5.CrossRefPubMed

Mizuno S, Fujita K, Furuya R, Hishid A, Ito H, Tashim Y, et al. Association of HSP73 with the acquired resistance to uranyl acetate-induced acute renal failure. Toxicology. 1997;117:183–91.CrossRefPubMed

10.

Sano K, Fujigaki Y, Miyaji T, Ikegaya N, Ohishi K, Yonemura K, et al. Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate. Kidney Int. 2000;57:1560–70.CrossRefPubMed

11.

Ikuma K, Honda N, Hishida A, Nagase M. Loss of glomerular responses to vasoconstrictor agents in rabbits recovering from ARF. Kidney Int. 1986;30:836–41.CrossRefPubMed

12.

Sun Y, Fujigaki Y, Sakakima M, Hishida A. Acquired resistance to rechallenge injury in rats recovered from subclinical renal damage with uranyl acetate—importance of proliferative activity of tubular cells. Toxicol Appl Pharmacol. 2010;243:104–10.CrossRefPubMed

13.

Mehendale HM, Thakore KN, Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol. 1994;9:131–9.CrossRefPubMed

14.

Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. Role of tissue repair in survival from s-(1, 2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol Sci. 2003;74:215–27.CrossRefPubMed

15.

Korrapati MC, Chilakapati J, Lock EA, Latendresse JR, Warbritton A, Mehendale HM. Preplaced cell division: a critical mechanism of autoprotection against S-1, 2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am J Physiol Renal Physiol. 2006;291:F439–55.CrossRefPubMed

16.

Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, et al. Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant. 2009;24:2686–92.CrossRefPubMed

17.

Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.CrossRefPubMed

18.

Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–53.CrossRefPubMed

19.

Rao VC, Mehendale HM. Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol. 1993;67:392–400.CrossRefPubMed

20.

Dalu A, Rao PS, Mehendale HM. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality. Environ Health Perspect. 1998;106:597–606.CrossRefPubMedPubMedCentral

21.

Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23:2198–205.CrossRefPubMed

22.

Qiu J, Liu Z, Da L, Li Y, Xuan H, Lin Q, et al. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4. J Hepatol. 2007;46:266–75.CrossRefPubMed

23.

Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, et al. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med. 2006;17:857–64.PubMed

24.

Del Signore A, De Sanctis V, Di Mauro E, Negri R, Perrone-Capano C, Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J Neurosci. 2006;23:65–74.CrossRefPubMed

25.

Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, et al. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. 2006;21:41–50.CrossRefPubMed

26.

Li C, Yang CW, Ahn HJ, Kim WY, Park CW, Park JH, et al. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Nephron. 2002;92:422–30.CrossRefPubMed

27.

Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;297:F200–9.CrossRefPubMed

28.

Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258–61.CrossRefPubMed

29.

Seville LL, Shah N, Westwell AD, Chan WC. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets. 2005;5:159–70.CrossRefPubMed

30.

Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol. 2001;280:F562–73.CrossRefPubMed

31.

Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93:2175–88.CrossRefPubMedPubMedCentral

32.

Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol. 2006;290:R861–70.CrossRefPubMed

33.

Liu KD, Brakeman PR. Renal repair and recovery. Crit Care Med. 2008;36:S187–92.CrossRefPubMed

34.

Imai E, Isaka Y. Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens. 2002;11:49–57.CrossRefPubMed

35.

Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol. 2001;12:531–40.PubMed

36.

Tajima H, Higuchi O, Mizuno K, Nakamura T. Tissue distribution of hepatocyte growth factor receptor and its exclusive downregulation in a regenerating organ after injury. J Biochem. 1992;111:401–6.CrossRefPubMed

37.

Leshem Y, Halevy O. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent. J Cell Physiol. 2002;191:173–82.CrossRefPubMed

Titel: Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis
verfasst von: Yuan Sun
Yoshihide Fujigaki
Masanori Sakakima
Tomoyuki Fujikura
Akashi Togawa
Yanjie Huang
Akira Hishida
Publikationsdatum: 01.10.2011
Verlag: Springer Japan
Erschienen in: Clinical and Experimental Nephrology / Ausgabe 5/2011
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-011-0453-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats

Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome

Successful treatment of progressive renal injury due to granulomatous tubulointerstitial nephritis with uveitis

Renal amyloidosis caused by apolipoprotein A-II without a genetic mutation in the coding sequence

Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function